Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HOUSE CATASTROPHIC CARE DEBATE EXPECTED TO INCLUDE REPEAL AMENDMENT, SPEAKER FOLEY PREDICTS; FLOOR CONSIDERATION EXPECTED TO BEGIN SEPT. 27

Executive Summary

House floor debate on Medicare catastrophic coverage modifications are likely to include an amendment to repeal the law, House Speaker Foley (Wash.) said at a Sept. 21 press conference. Foley predicted that discussion of a repeal will be permitted during floor debate of the budget reconciliation bill. The bill includes a Ways & Means Committee plan to make the program voluntary, raise the drug deductible, and decrease supplemental premiums while increasing flat premiums. The House Rules Committee is expected to vote Sept. 25 on the rule governing floor debate on the fiscal 1990 budget reconciliation package. Under House procedures, only those amendments listed in the rule may be offered on the floor. The full House is expected to vote on the rule for floor debate Sept. 25-26; consideration of the bill itself is tentatively scheduled to begin on Sept. 27. The Rules Committee heard testimony for and against repeal of the Catastrophic Coverage Act at a Sept. 21 hearing but did not proceed to a vote. If permitted, the repeal amendment is expected to be offered by Reps. Donnelly (D-Mass.) and Archer (R-Texas). "We will probably make 'in order' an opportunity for members to vote for repeal," Foley said. Foley also said he expected that members will be permitted to vote separately on whether to waive the requirements of the Gramm-Rudman-Hollings budget law in the case of a repeal, which could lead to substantial budget deficit. Foley said that he favored modification of the catastrophic care program, as proposed by Ways & Means, over an outright repeal. House Budget Committee Chairman Panetta (D-Calif.) reportedly told the Rules Committee a flat repeal of the law would lead to a $ 4 to $ 5 bil. loss in revenue for fiscal 1990 and would require a waiver of Gramm-Rudman. Panetta and Budget Committee Ranking Minority Member Frenzel (Minn.) urged the Rules Committee to resist the movement to repeal the law.

You may also be interested in...



Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance

FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials

Shire Hopes To Sow Future Deals With $50M Venture Fund

Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth

UsernamePublicRestriction

Register

OM006922

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel